This Commentary article revisits the development and implementation of mobile health data, exploring how initiatives such as the NHS track and trace system helped to mitigate the worst of the impact of the Covid-19 pandemic. Here, we consider the applications of mHealth data for present and future pandemic situations.
This Commentary piece looks at the means by which the global approval process for new medicines can be sped up through the controlled use of FAIR data. Key areas of focus include the sharing of healthcare data to bring the patient voice within the clinical setting.
The amount of data created by pharmaceutical companies has increased exponentially over the last few decades. Managing these enormous volumes of data can be challenging, an issue compounded by a lack of standardisation. Data is often gathered from numerous sources and devices and stored separately, making it difficult to retrieve, query, share and analyse.
This September, our PharmaTec series discussion group focused on cutting edge data analytics. Some of the key topics our experts covered included whether analytics should start with the data or a use case first, different analytical platforms and the application of AI/ML technologies.
Workshop Speakers Include: Lena Granovsky, Senior Director, Head of Analytics & Big Data, Teva | Ajay Shah, Executive Director and Head of IT for Translational Medicine, Bristol-Myers Squibb | Edwin Trautman, Vice President, Science, Clinical Analyticsand Informatics, Pfizer | Victoria Gamerman, Head of US Health Informatics & Analytics, Boehringer Ingelheim | Dunja Petrovic, Scientific Data Analyst, MSD
31 July 2020
Search by Keyword
Filter by Subject Area
Filter by Content Type
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.